Ana Margarida Abrantes Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Professor

John Brown University

faculty

35 h-index 363 pubs 4,485 cited

Research Areas

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Ana Margarida Abrantes is a Professor at John Brown University whose research is focused on cancer theranostics, with specific interests in hypoxia, metabolism, and the applications of nanoplatforms. Her work encompasses diverse methodologies, from photodynamic therapy to radiopharmaceutical chemistry and medical imaging. Recent research has included investigations of metabolomic profiling in lung cancer and explorations of cold atmospheric plasma as a novel approach against bladder cancer. She also examines innovative cell culturing techniques, such as magnetic-based 3D models for human tissue. In addition, Abrantes has contributed to the study of dental materials, including evaluations of the sealing ability and bond strength of endodontic root canal sealers using radioactive isotope methods.

Metrics

h-index: 35
Publications: 363
Citations: 4,485

Selected Publications

Radiobiological Modeling with Monte Carlo Tools – Simulating Cellular Responses to Ionizing Radiation (2025) DOI
Tumor Resection in Hepatic Carcinomas Restores Circulating T Regulatory Cells (2024) DOI
The adipose tissue melanocortin 3 receptor is targeted by ghrelin and leptin and may be a therapeutic target in obesity (2024) DOI
348 Gene expression signatures associated with Class I variants: commonalities and specificities (2024) DOI
Gene expression changes following chronic antipsychotic exposure in single cells from mouse striatum (2024) DOI
Predicting colorectal cancer liver metastases histological growth patterns: inflammation on the primary tumor is associated with desmoplastic growth pattern (2024) DOI
Steroidal epoxides as anticancer agents in lung, prostate and breast cancers: The case of 1,2-epoxysteroids (2024) DOI
Anti-Algics in the Therapeutic Response of Breast and Urological Cancers (2023) DOI
Impact of Different Treatment Regimens and Timeframes in the Plasmatic Metabolic Profiling of Patients with Lung Adenocarcinoma (2023) DOI
Risk of Second Tumors in Retinoblastoma Survivors after Ionizing Radiation: A Review (2023) DOI
Influence of the therapeutic approach in the metabolomic profile evolution of Lung Adenocarcinoma patients (2023) DOI
80P Steroidal oximes: A new potential therapeutic approach for cancer treatment (2023) DOI
66P Exploring the radiobiology and dosimetry of targeted alpha therapy as a tool to optimize its clinical application: A preclinical study (2023) DOI
89P Cold atmospheric plasma-activated fluids as a potential new intravesical agent for the treatment of bladder cancer (2023) DOI
Basic Concepts of Radiation Biology (2023) DOI